Company information is based on published SEC data. Scores and reviews appear only after a genuine contribution is published.

US · 0000318154

AMGEN INC

United States · Biological Products, (No Diagnostic Substances) · Data as of 2026-08-06

Get notified when a new evaluation is published.

Company profile

Legal name
AMGEN INC
Country of registration
United States
Registration ID
0000318154 (SEC CIK)
Industry
Biological Products, (No Diagnostic Substances)
Head office
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Main switchboard
(805)447-1000
Website
https://www.amgen.com
Data as of
2026-08-06
Evaluations
0

Overall score

No evaluations yet

Nothing on this page is estimated or inferred. The nine criteria, the score distribution, the trend and the commercial terms stay empty until a vendor who worked with this company publishes an evaluation.

Submit an evaluation

What will appear here

Averages for these nine criteria

  1. Payment reliability
  2. Quality of requirements
  3. Decision timeliness
  4. Day-to-day collaboration
  5. Fair contracting & change control
  6. Information transparency
  7. Respect for vendor expertise
  8. Willingness to work again
  9. Openness to new technology

Alongside them

  • The overall score, with the number of evaluations behind it
  • The distribution of individual evaluations
  • Six-month averages, so direction is visible as well as position
  • Payment terms, currencies, governing law and typical engagement value
How these scores are calculated

Engagement reviews

Contributor names and companies are not published.

No engagement evaluations have been submitted for this company yet.

Submit an evaluation

This is my company

Respond to a review, or dispute a record.